|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 409 12th Street, SW |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Michela Masson |
Date | 10/18/2018 10:47:52 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control and Prevention (CDC); Agency for Healthcare Research and Quality (AHRQ); Comprehensive Sexuality Education (general); American Indian/Alaska Native womens health (general) (IHS); International Family Planning; Department of Defense (DOD) Defense Health Research Programs, Ovarian Cancer Research Program; Health Disparities (HHS); Safe Motherhood (CDC); Preterm Birth Research (NIH); Maternal Morbidity and Mortality (CDC, HRSA); Alliance for Innovation on Maternal Health (HRSA); Immunization (HHS); Tobacco Regulation (FDA); Smoking Cessation (general) (CDC, FDA); Gun Violence Research (general) (CDC); Vital Statistics (CDC); Maternal Therapeutics Research and Regulation (HHS, NIH, FDA); Prevention and Public Health Fund (CDC); Title V Block Grant (HRSA); Title X, Family Planning (OPA); Teen Pregnancy Prevention Program (OAH); Adolescent HIV Prevention Program (CDC); Global Maternal and Child Health (USAID); Reproductive Health (general); Gynecologic Health (general); Birth Defects (CDC); Assisted Reproductive Technology (VA); Newborn Screening (CDC, HRSA); Preterm Birth (CDC, HRSA, NIH); Medicaid and Medicare (CMS); Division of Reproductive Health (CDC); Pregnancy Risk Assessment Monitoring System (CDC); National Center for Birth Defects and Developmental Disabilities (CDC); Breast Cancer Screening (HHS), Division of STD Prevention (CDC); Fetal Tissue Research (NIH); National Health Service Corps (HRSA); Office on Smoking and Health (CDC); Substance Use Disorder Treatment (SAMHSA); Women, Infants, and Children Nutrition Program (USDA); Child Welfare (ACF); Postpartum Depression (HRSA); P.L. 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC), Office of Management & Budget (OMB), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Agency for Healthcare Research & Quality (AHRQ), Substance Abuse & Mental Health Services Administration (SAMHSA), Food & Drug Administration (FDA), U.S. Agency for International Development (USAID), Indian Health Service, Administration for Children & Families (ACF), Veterans Affairs - Dept of (VA), Homeland Security - Dept of (DHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Rebecca |
Nathanson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Health Disparities (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Lab Developed Tests (general); Contraception (general); Preeclampsia (general); Over the Counter Drugs (general); National Health Service Corps (general); Community Health Centers (general); Abortion (general); Hyde Amendment (General); Indian Health (general); Teaching Health Centers (general); Teen Pregnancy Prevention Program (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Health Care Reform (general); Title X (general); Personal Responsibility Education Program (general); Womens Preventive Services (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. 5977, MOMMAs Act; H.R.5761, Ending Maternal Mortality Act of 2018; S. 3392, MOMs Act; S. 3363, Maternal CARE Act; S.3494, MOMMIES Act; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; S.2852/H.R. 6378 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; S. 783, Improving Access to Maternity Care Act; S.Res. 605, A resolution designating the first week in August as World Breastfeeding Week, and designating August as National Breastfeeding Month; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; H.R. 6085/S. 3029, the PREEMIE Reauthorization Act; H.R. 3692, Addiction Treatment Access Improvement Act; S. 2680, Opioid Crisis Response Act; H.R. 5818/S. 2843, the Opioid Workforce Act of 2018; H.R. 2501/S. 1148, CRIB Act; H.R. 4993/ S.3253 - Vaccine Access Improvement Act of 2018; H.R. 6, SUPPORT for Patients and Communities Act; H.R. 6805, Pregnant Women in Custody Act; S. 2960 Access to Infertility Treatment and Care Act; H.J.Res. 140/S.J.Res. 63, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, Department of Labor, and the Department of Health and Human Services relating to Short-Term, Limited Duration Insurance; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act; H.R. 6545/S.___, Violence Against Women Reauthorization Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS), Substance Abuse & Mental Health Services Administration (SAMHSA), Office of Management & Budget (OMB), White House Office, Executive Office of the President (EOP), Office of Natl Drug Control Policy (NDCP), Indian Health Service, Justice - Dept of (DOJ), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Rebecca |
Nathanson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Childrens Health Insurance Program (CHIP); Implementation of P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015; Medicaid (general); Medicare (general); Medicare reimbursement (general); Health Care Reform (general); S. 3160, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Rebecca |
Nathanson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
P.L. 115-232, National Defense Authorization Act for Fiscal Year 2019; Congressionally Directed Medical Research Programs (CDMRP); Ovarian cancer (general); Gynecologic cancer (general); Contraception Access (general); Emergency Contraception (general); Military Sexual Trauma (general); Military Womens Health (general); Maternity Care (general); Postpartum care (general); Assisted Reproductive Technology (general); H.R. 2180/S. 957, Access to Contraception for Women Servicemembers and Dependents Act; S. 700 Women Veterans and Families Health Services Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Rebecca |
Nathanson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Implementation of P.L. 114-182, Frank R. Lautenberg Chemical Safety for the 21st Century Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Rebecca |
Nathanson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Assisted Reproductive Technology (general); Gender based health services (general); Provider scope of practice (general); Military Sexual Trauma (general); Abortion (general); H.R.1681/S. 700 Women Veterans and Families Health Services Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Rebecca |
Nathanson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Immigration and womens health (general); Health care work force (general); Public Charge; Abortion (general); Pregnant women in immigration detention; S. 3225, Stop Shackling and Detaining Pregnant Women Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Rebecca |
Nathanson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Family planning (general); Maternal health (general).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Agency for International Development (USAID), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Rachel |
Tetlow |
|
|
|
Mallory |
Schwarz |
|
|
|
Rebecca |
Nathanson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |